Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers. February 28, 2018 ARTICLE CITATION DOI: 10.1200/JCO.2018.78.2425 Journal of Clinical Oncology - published online before print April 23, 2018 PMID: 29683789 DNA Repair Deficiency and Immunotherapy Response Kent W. MouwxKent W. MouwSearch for articles by this author and Alan D. D'AndreaxAlan D. D'AndreaSearch for articles by this author Show More Kent W. Mouw, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA; and Alan D. D'Andrea, Dana-Farber Cancer Institute, Boston, MA https://doi.org/10.1200/JCO.2018.78.2425 First Page Full Text PDF Figures and Tables © 2018 by American Society of Clinical Oncology Companion Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers
No takes yet. Share an insight, caveat, or question.
Mouw et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: